Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.40 +0.41 (+2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Long-Term Debt Issuances (2013 - 2023)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) reported Long-Term Debt Issuances of $55 million for FY2025.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Long-Term Debt Issuances (2013 - 2023) Analysis & Trends

Dating back to FY2013, Viridian Therapeutics, Inc.\DE's Long-Term Debt Issuances record includes 7 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of 99.8% (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual Long-Term Debt Issuances in data going back to FY2013.
  • According to Business Quant data, Long-Term Debt Issuances came in at $15 million in FY2023 (+200.0%) and $5 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Viridian Therapeutics, Inc.\DE 2.20 Bn 2.20 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 15.00 Mn
Dec 31, 2022 446,000.00
Jun 30, 2014 695,000.00
Mar 31, 2014 100,000.00
Dec 31, 2013 749,817.00
Sep 30, 2013 601,456.00
API Access

Viridian Therapeutics, Inc.\DE Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VRDN&period=max&api_key=YOUR_API_KEY